Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Lena‐Christin Conradi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9488-1018; OpenAlex author ID A5028799363. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 4 papers

Papers 7

  1. Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117649↗
  2. GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair. Co-author DOI 10.1136/gutjnl-2025-336227↗
  3. Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam. Co-author DOI 10.1158/2767-9764.crc-25-0670↗
  4. Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12943-026-02628-3↗
  5. KRAS G 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening. Co-author DOI 10.1002/1878-0261.13725↗
  6. OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data. Co-author DOI 10.1007/s13402-024-00958-2↗
  7. HAPLN1 potentiates peritoneal metastasis in pancreatic cancer. Co-author DOI 10.1038/s41467-023-38064-w↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Günter Schneider · 4 shared papers, 2025–2026 · strength 0.77
  2. Elisabeth Heßmann · 4 shared papers, 2025–2026 · strength 0.77
  3. Volker Ellenrieder · 3 shared papers, 2025–2026 · strength 0.58
  4. Tiago De Oliveira · 3 shared papers, 2025–2026 · strength 0.58
  5. Michael B. Ghadimi · 3 shared papers, 2025–2026 · strength 0.57
  6. Carolin Schneider · 3 shared papers, 2025–2026 · strength 0.57
  7. Ulrich Sax · 3 shared papers, 2025–2026 · strength 0.56
  8. Nathalia Luisa Carlos Ferreira · 2 shared papers, 2025–2026 · strength 0.43
  9. Shiv K. Singh · 2 shared papers, 2026 · strength 0.42
  10. Lukas Klein · 2 shared papers, 2026 · strength 0.42
  11. Argyris Papantonis · 2 shared papers, 2026 · strength 0.41
  12. Gabriela Salinas · 2 shared papers, 2025–2026 · strength 0.39
  13. Marian Grade · 2 shared papers, 2025–2026 · strength 0.38
  14. Maximilian Reichert · 2 shared papers, 2025–2026 · strength 0.38
  15. Lukas Krauß · 2 shared papers, 2025–2026 · strength 0.38
  16. Matthias Wirth · 2 shared papers, 2025–2026 · strength 0.38
  17. Dieter Saur · 2 shared papers, 2025–2026 · strength 0.38
  18. Fernanda Ramos‐Gomes · 1 shared paper, 2025 · strength 0.24
  19. Frauke Alves · 1 shared paper, 2025 · strength 0.24
  20. Olaf Hardt · 1 shared paper, 2025 · strength 0.24
  21. M. Andrea Markus · 1 shared paper, 2025 · strength 0.24
  22. Ajinkya Kulkarni · 1 shared paper, 2025 · strength 0.24
  23. Adi Danieli‐Mackay · 1 shared paper, 2026 · strength 0.22
  24. Emre Taylan Duman · 1 shared paper, 2026 · strength 0.22
  25. Matthias Dobbelstein · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.